Winder Laboratories recalls Multivitamin with Fluoride Chewable Tablets because they have too little vitamin D
An FDA inspection found the grape-flavored chewable tablets, sold in 0.25 mg and 1 mg strengths, contain less vitamin D than they should.
What to do
The notice does not give instructions. Read the official notice for details.
Recall details
- Product
- Multivitamin with Fluoride Chewable Tablets Grape Flavor Rx NDC 75826-169-10 0.25 mg 100 TABLETS UPC 3 15826 16910 2; NDC 75826-171-10 1mg 100 TABLETS UPC 3 15826 17110 5 Manufactured by: WINDER LABORATORIES LLC Winder, GA 30680
- Company
- Winder Laboratories, LLC
- Hazard
- Subpotent. During an FDA inspection it was discovered that the product was subpotent for Vitamin D.
- Units
- 422cs/12/0.25mg/100ct bottles + 210cs/12/1.0mg/100ct bottles
- Where sold
- Product was shipped to the following states: AL, AZ, CA, FL, HI, IA, IL, IN, MA, MI, MO, MS, NC, NJ, NY, OR, PA, PR, RI, TN, TX, UT, WA, WI & WV.
- FDA classification
- Class III · Ongoing
- Classified by FDA
- March 13, 2026
- Recall started
- October 27, 2025
- FDA enforcement report
- March 25, 2026
- Identifiers
- Codes: Lot 1692303 SN: 138909557498 EXP: 2025-10-26 & Lot 1692304 SN 131163901709 EXP: 2025-10-26; LOT 1712301 SN: 163590222021 EXP: 2025-11-14
- FDA recall number: H-0569-2026
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- Multivitamin with Fluoride Chewable Tablets Grape Flavor Rx NDC 75826-169-10 0.25 mg 100 TABLETS UPC 3 15826 16910 2; NDC 75826-171-10 1mg 100 TABLETS UPC 3 15826 17110 5 Manufactured by: WINDER LABORATORIES LLC Winder, GA 30680
- Reason for recall
- Subpotent. During an FDA inspection it was discovered that the product was subpotent for Vitamin D.
- Classification
- Class III (Ongoing)
- Distribution
- Product was shipped to the following states: AL, AZ, CA, FL, HI, IA, IL, IN, MA, MI, MO, MS, NC, NJ, NY, OR, PA, PR, RI, TN, TX, UT, WA, WI & WV.
- Quantity
- 422cs/12/0.25mg/100ct bottles + 210cs/12/1.0mg/100ct bottles
Related recalls
Dr. Reddy's recalls varenicline 1mg tablets because they are weaker than intended
In a 9-month stability test, the affected lot tested below the allowed strength, which means the tablets contain less of the drug than they should.
Dr. Reddy's Laboratories, Inc. · 4800 54-count bottles
Major Pharmaceuticals recalls levothyroxine sodium tablets because they may be weaker than labeled
The recalled levothyroxine tablets (75 mcg, 88 mcg and 150 mcg strengths) are subpotent, meaning they contain less medicine than the label says.